Hence, this study was designed to investigate the role of DLGAP5 as a biomarker in pancreatic cancer and explore the possible underlying mechanisms of DLGAP5 in tumorigenesis. This evidence concerns the gene DLGAP5 and familial pancreatic carcinoma.